Clinical trials · New York, NY
Monoclonal Gammopathy of Undetermined Significance clinical trials in New York
We’re tracking 3 recruiting monoclonal gammopathy of undetermined significance studies with a site in or near New York — including Phase 2 studies, each written for real people, not researchers.
Recruiting studies near New York
- NCT06140524RecruitingPhase 2
Study of Linvoseltamab for high-risk MGUS or smoldering myeloma
This trial tests if linvoseltamab can remove abnormal plasma cells that might turn into multiple myeloma. It is for patients with high-risk MGUS (a precancerous condition) or non-high-risk smoldering myeloma who have not yet developed active myeloma.
New York, New YorkAges 18 years+ - NCT05640843Recruiting
Plant-based diet study for MGUS or smoldering myeloma
This trial tests whether a whole-food, plant-based eating pattern—plus supplements or placebo—can improve health outcomes in people with MGUS or smoldering multiple myeloma. You may be asked to follow specific recipes and stop certain supplements, so it helps to confirm you can stick with the plan.
New York, New YorkAges 18 years+ - NCT06055894Recruiting
Plant-based diet and supplements for smoldering myeloma or MGUS
This study tests whether a plant-based diet and certain supplements can help people with smoldering multiple myeloma (SMM) or monoclonal gammopathy of undetermined significance (MGUS). Participants will learn to cook plant-based recipes and track their meals using a phone app.
New York, New YorkAges 18 years+
Hear when a new Monoclonal Gammopathy of Undetermined Significance trial opens near New York, NY
We’ll email you when one opens near New York, NY — at most once a week, no account needed, unsubscribe anytime.
Where these studies are running near New York
Institutions with a site for the recruiting monoclonal gammopathy of undetermined significance studies listed above.
- Memorial Sloan Kettering Basking Ridge · 2 studies
- Memorial Sloan Kettering Bergen · 2 studies
- Memorial Sloan Kettering Cancer Center · 2 studies
- Memorial Sloan Kettering Cancer Center - Westchester · 2 studies
- Memorial Sloan Kettering Commack · 2 studies
- Memorial Sloan Kettering Monmouth · 2 studies
- Memorial Sloan Kettering Nassau · 2 studies
- NYU Langone Health Perlmutter Cancer Center
What taking part in a monoclonal gammopathy of undetermined significance study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting monoclonal gammopathy of undetermined significance studies in New York.
Common questions
- Are there monoclonal gammopathy of undetermined significance clinical trials near New York?
- Yes. We're currently tracking 3 recruiting monoclonal gammopathy of undetermined significance studies with a site near New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a monoclonal gammopathy of undetermined significance study near New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site near New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a monoclonal gammopathy of undetermined significance trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New monoclonal gammopathy of undetermined significance studies open near New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.